Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ KeyBanc Cuts On Holding Price Target to $43: Tariff Concerns Pressure the Growth Story (24/7 Wall St.) +++ ON HOLDING Aktie +3,63%

INNOCAN Aktie

 >INNOCAN Aktienkurs 
3.08 EUR    -4.4%    (TradegateBSX)
Ask: 3.29 EUR / 1500 Stück
Bid: 3.08 EUR / 250 Stück
Tagesumsatz: 1476 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
INNOCAN Aktie über LYNX handeln
>INNOCAN Performance
1 Woche: -8,0%
1 Monat: -17,6%
3 Monate: -32,4%
6 Monate: -67,0%
1 Jahr: 0%
laufendes Jahr: -21,8%
>INNOCAN Aktie
Name:  INNOCAN PHARMA CORP.
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA45783P5085 / A41FTP
Symbol/ Ticker:  IP40 (Frankfurt)
Kürzel:  FRA:IP40, ETR:IP40, IP40:GR
Index:  -
Webseite:  https://innocanpharma.com..
Profil:  InnoCan Pharma Corporation is a pharmaceutical technology company founded in 2018 and headquartered in Calgary, Canada. It specializes in innovative drug delivery platforms that combine cannabidiol (CBD) with other pharmaceutical ingredients to treat..
>Volltext..
Marktkapitalisierung:  16.44 Mio. EUR
Unternehmenswert:  13.74 Mio. EUR
Umsatz:  23.1 Mio. EUR
EBITDA:  -1.03 Mio. EUR
Nettogewinn:  -0.96 Mio. EUR
Gewinn je Aktie:  -0.21 EUR
Schulden:  0.79 Mio. EUR
Liquide Mittel:  5.73 Mio. EUR
Operativer Cashflow:  -
Bargeldquote:  4.97
Umsatzwachstum:  -14.59%
Gewinnwachstum:  42.14%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  INNOCAN
Letzte Datenerhebung:  13.05.26
>INNOCAN Kennzahlen
Aktien/ Unternehmen:
Aktien: 4.5 Mio. St.
Frei handelbar: 77.34%
Leerverk. Aktien: -
Rückkaufquote: -2.73%
Mitarbeiter: -
Umsatz/Mitarb.: -
Analysten:
Analystenrating: No rating
Kursziel: -
Bewertung:
KGV: -
KGV lG: -
KUV: 0.67
KBV: 3.17
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: 89.94%
Gewinnmarge: -4.17%
Operative Marge: -4.6%
Managementeffizenz:
Gesamtkaprendite: -11.19%
Eigenkaprendite: -20.54%
>INNOCAN Peer Group
Gesundheit, Neurologie/ psychische Behandlung/ Schlaganfälle
 
06.05.26 - 22:03
 Innocan Pharma LPT-CBD is featured in Pain Medicine News (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, May 6, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries is pleased to announce that its novel Liposomal Delivery Platform for......
06.04.26 - 12:57
 Innocan Pharma Announces Closing of Additional Debenture (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, April 6, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it has closed its previously announced offering of an additional debenture of the Company (the......
02.04.26 - 20:12
 Innocan Pharma reports FY results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
31.03.26 - 16:21
 Innocan Pharma Announces Offering of an Additional Debenture to Tamar Innovest (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, March 31, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to complete an offering of a debenture of the Company (the "Debenture") to its largest......
31.03.26 - 09:03
 Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, March 31, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, is pleased to announce......
16.03.26 - 22:07
 Innocan Pharma Announces Closing of a Debenture to its Largest Shareholder, Tamar Innovest (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, March 16, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it has closed its previously announced offering of a debenture of the Company (the "Debenture") to its......
11.03.26 - 23:45
 Innocan Pharma Announces Offering of a Debenture to its Largest Shareholder, Tamar Innovest (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, March 11, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to complete an offering of a debenture of the Company (the "Debenture") to its largest......
27.02.26 - 22:33
 FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, Feb. 27, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that the FDA's Center for Veterinary......
09.02.26 - 17:01
 Innocan Pharma gibt Ergebnisse einer randomisierten, verblindeten klinischen Studie mit Hunden bekannt: LPT-CBD ist Placebo bei Schmerzlinderung überlegen (IRW Press)
 
Herzliya, Israel und Calgary, Alberta 9. Februar 2026 / IRW-Press / Innocan Pharma Corporation (CSE: INNO) (FWB: IP40) (OTCQB: INNPD) (Innocan oder das Unternehmen), ein Vorreiter auf dem Gebiet der......
09.02.26 - 15:12
 Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, Feb. 9, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces the publication of a research article titled......
27.01.26 - 22:18
 Innocan Pharma Corporation plant Listing an der NYSE American Stock Exchange mit gleichzeitigem Emissionsangebot (IRW Press)
 
Herzliya, Israel und Calgary, AB 27. Januar 2026 / IRW-Press / Innocan Pharma Corporation (CSE: INNO) (FWB: IP4) (OTCQB: INNPF) (das Unternehmen oder Innocan), ein pharmazeutisches......
27.01.26 - 22:03
 Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, Jan. 27, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, today announced that,......
02.01.26 - 13:06
 Innocan Pharma Corporation plant Listing an der NYSE American Stock Exchange mit gleichzeitigem Emissionsangebot (IRW Press)
 
Herzliya, Israel und Calgary, AB - 2. Januar 2026 / IRW-Press /  Innocan Pharma Corporation (CSE: INNO) (FWB: IP4) (OTCQB: INNPF) (das Unternehmen oder Innocan), ein pharmazeutisches......
02.01.26 - 13:02
 Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering (PR Newswire)
 
HERZLIA, Israel and CALGARY, AB, Jan. 2, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, today announced that it......
10.12.25 - 16:42
 Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, Dec. 10, 2025 /PRNewswire/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that, further to its press release of July 23, 2025, it has publicly filed an amendment to its registration......
27.11.25 - 19:54
 InnoCan Pharma nach Q3-Zahlen: Kursrückgang überschattet hohe Margen und strategische Pläne (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
27.11.25 - 11:31
 Innocan Pharma gibt Finanzergebnisse für 3. Quartal 2025 bekannt mit Umsätzen von 21,6 Mio. USD (IRW Press)
 
Herzliya, Israel und Calgary, Alberta 27. November 2025 / IRW-Press / Innocan Pharma Corporation (CSE: INNO) (FWB: IP4) (OTC: INNPF) (das Unternehmen oder Innocan), ein pharmazeutisches......
27.11.25 - 07:36
 Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, Nov. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, is pleased to announce......
24.11.25 - 22:06
 Innocan Pharma meldet vielversprechende translationale Evidenz aus einer Schmerzlinderungsstudie zur wiederholten Verabreichung von LPT-CBD an Ziegen (IRW Press)
 
Herzliya, Israel und Calgary, Alberta 24. November 2025 / IRW-Press / Innocan Pharma Corporation (CSE: INNO) (FWB: IP40) (OTCQB: INNPD) (Innocan oder das Unternehmen), ein Vorreiter auf dem Gebiet......
24.11.25 - 22:03
 Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats (PR Newswire)
 
HERZLIYA, Israel and CALGARY, Alberta, Nov. 24, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces the publication of a research article titled......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Denn wenn es Kunst ist, ist sie nicht für alle, und wenn sie für alle ist, ist sie keine Kunst. - Arnold Schönberg
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!